+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hemophilia Treatment Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4770286
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
UP TO OFF
until Dec 31st 2019
1 of 3

FEATURED COMPANIES

  • Bayer AG
  • Biotest AG
  • CSL Limited
  • F. Hoffmann-La Roche Ltd
  • Kedrion S.p.A
  • Novo Nordisk A/S
  • MORE
The report on the global hemophilia treatment drugs market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global hemophilia treatment drugs market to grow with a CAGR of 7.25% over the forecast period from 2019-2025. The study on hemophilia treatment drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on hemophilia treatment drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global hemophilia treatment drugs market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global hemophilia treatment drugs market over the period of 2017 to 2025. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
  • Advancement in technology
  • Increasing awareness regarding hemophilia
2) Restraints
  • High cost associated with the treatment of hemophilia diseases
3) Opportunities
  • Advancement in gene therapy
Research Methodology
A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with the Publisher
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global hemophilia treatment drugs market is segmented on the basis of product type, disease indication, and distribution channel.

The Global Hemophilia Treatment Drugs Market by Product Type
  • Desmopressin
  • Plasma Derived Coagulation Factor Concentrates
  • Antifibrinolytic Agents
  • Recombinant Coagulation Factor Concentrates
The Global Hemophilia Treatment Drugs Market by Disease Indication
  • Hemophilia A
  • Hemophilia B
  • Polyethylene
The Global Hemophilia Treatment Drugs Market by Distribution Channel
  • E-Commerce
  • Retail Pharmacies
  • Hospital Pharmacies
Company Profiles
The companies covered in the report include
  • Takeda
  • Biotest AG
  • Sanofi
  • Bayer AG
  • Pfizer Inc
  • CSL Limited
  • Octapharma
  • F. Hoffmann-La Roche Ltd
  • Novo Nordisk A/S
  • Kedrion S.p.A
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the hemophilia treatment drugs market.
2. Complete coverage of all the segments in the hemophilia treatment drugs market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global hemophilia treatment drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Bayer AG
  • Biotest AG
  • CSL Limited
  • F. Hoffmann-La Roche Ltd
  • Kedrion S.p.A
  • Novo Nordisk A/S
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Hemophilia Treatment Drugs Market Highlights
2.2. Hemophilia Treatment Drugs Market Projection
2.3. Hemophilia Treatment Drugs Market Regional Highlights

3. Global Hemophilia Treatment Drugs Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Product Type
3.4.2. IGR-Growth Matrix Analysis by Disease Indication
3.4.3. IGR-Growth Matrix Analysis by Distribution Channel
3.4.4. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Hemophilia Treatment Drugs Market

4. Hemophilia Treatment Drugs Market Macro Indicator Analysis

5. Global Hemophilia Treatment Drugs Market by Product Type
5.1. Desmopressin
5.2. Plasma Derived Coagulation Factor Concentrates
5.3. Antifibrinolytic Agents
5.4. Recombinant Coagulation Factor Concentrates

6. Global Hemophilia Treatment Drugs Market by Disease Indication
6.1. Hemophilia A
6.2. Hemophilia B
6.3. Polyethylene

7. Global Hemophilia Treatment Drugs Market by Distribution Channel
7.1. E- Commerce
7.2. Retail Pharmacies
7.3. Hospital Pharmacies

8. Global Hemophilia Treatment Drugs Market by Region 2019-2025
8.1. North America
8.1.1. North America Hemophilia Treatment Drugs Market by Product Type
8.1.2. North America Hemophilia Treatment Drugs Market by Disease Indication
8.1.3. North America Hemophilia Treatment Drugs Market by Distribution Channel
8.1.4. North America Hemophilia Treatment Drugs Market by Country
8.2. Europe
8.2.1. Europe Hemophilia Treatment Drugs Market by Product Type
8.2.2. Europe Hemophilia Treatment Drugs Market by Disease Indication
8.2.3. Europe Hemophilia Treatment Drugs Market by Distribution Channel
8.2.4. Europe Hemophilia Treatment Drugs Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Hemophilia Treatment Drugs Market by Product Type
8.3.2. Asia-Pacific Hemophilia Treatment Drugs Market by Disease Indication
8.3.3. Asia-Pacific Hemophilia Treatment Drugs Market by Distribution Channel
8.3.4. Asia-Pacific Hemophilia Treatment Drugs Market by Country
8.4. RoW
8.4.1. RoW Hemophilia Treatment Drugs Market by Product Type
8.4.2. RoW Hemophilia Treatment Drugs Market by Disease Indication
8.4.3. RoW Hemophilia Treatment Drugs Market by Distribution Channel
8.4.4. RoW Hemophilia Treatment Drugs Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Hemophilia Treatment Drugs Market
9.2. Companies Profiles
9.2.1. Takeda
9.2.2. Biotest AG
9.2.3. Sanofi
9.2.4. Bayer AG
9.2.5. Pfizer Inc
9.2.6. CSL Limited
9.2.7. Octapharma
9.2.8. F. Hoffmann-La Roche Ltd
9.2.9. Novo Nordisk A/S
9.2.10. Kedrion S.p.A

10. Appendix
10.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Takeda
  • Biotest AG
  • Sanofi
  • Bayer AG
  • Pfizer Inc
  • CSL Limited
  • Octapharma
  • F. Hoffmann-La Roche Ltd
  • Novo Nordisk A/S
  • Kedrion S.p.A
Note: Product cover images may vary from those shown
Adroll
adroll